logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produswest2
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produswest2
Showing 1 - 6 of 6 Items
Showing 1 - 6 of 6 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Contribution des diagnostics au points de service dans l’identification de la maladie à VIH avancée

Ditondo P, Luemba A, Chuy RI, Mucinya G, Ade S
2023-08-01 • Public Health Action
2023-08-01 • Public Health Action
CONTEXTE
Médecins Sans Frontières Belgique a mis en place des diagnostics au point de service (DPS) pour le dépistage précoce d’un VIH avancé, et en présence de celle-ci, d’une TB et...
Journal Article
|
Research

Southern african HIV clinicians society guideline for the prevention, diagnosis and management of cryptococcal disease among HIV-infected persons: 2019 update

Govender NP, Meintjes GA, Mangena PM, Nel J, Potgieter S,  et al.
2019-11-08 • Southern African Journal of HIV medicine
2019-11-08 • Southern African Journal of HIV medicine
Journal Article
|
Research

High burden of cryptococcal antigenemia and meningitis among patients presenting at an emergency department in Maputo, Mozambique

Deiss R, Loreti C, Gutierrez AG, Filipe E, Tatia M,  et al.
2021-04-26 • PLOS One
2021-04-26 • PLOS One
BACKGROUND
Cryptococcal meningitis is a leading cause of HIV-related mortality in sub-Saharan Africa, however, screening for cryptococcal antigenemia has not been universally impleme...
Journal Article
|
Research

Time to embrace access programmes for medicines: Lessons from the South African flucytosine access programme

Shroufi A, Govender NP, Meintjes GA, Black JM, Nel J,  et al.
2020-06-01 • International Journal of Infectious Diseases
2020-06-01 • International Journal of Infectious Diseases
BACKGROUND
Cryptococcal Meningitis (CM) is estimated to cause 181,000 deaths annually; with the majority occurring in Sub Saharan Africa. Flucytosine is recommended by the World Heal...
Journal Article
|
Research

Outcomes of flucytosine-containing combination treatment for cryptococcal meningitis in a South African national access programme: a cross-sectional observational study

Mashau RC, Meiring ST, Quan VC, Nel J, Greene GS,  et al.
2022-06-21 • Lancet Infectious Diseases
2022-06-21 • Lancet Infectious Diseases
BACKGROUND
Although flucytosine is a key component of WHO-recommended induction treatment for HIV-associated cryptococcal meningitis, this antifungal agent is not widely available in...
Journal Article
|
Letter

Access to fluconazole in less-developed countries

Perez-Casas C, Chirac P, Berman D, Ford NP
2000-12-16 • Lancet
2000-12-16 • Lancet